BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 1674268)

  • 1. Lack of dose rate modification (0.0049 vs. 0.12 Gy/min) of fission-neutron-induced neoplastic transformation in C3H/10T1/2 cells.
    Balcer-Kubiczek EK; Harrison GH
    Int J Radiat Biol; 1991 Apr; 59(4):1017-26. PubMed ID: 1674268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of the constant exposure time technique to transformation experiments with fission neutrons: failure to demonstrate dose-rate dependence.
    Balcer-Kubiczek EK; Harrison GH; Torres BA; McCready WA
    Int J Radiat Biol; 1994 May; 65(5):559-69. PubMed ID: 7910195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogenic transformation of C3H/10T1/2 cells by X-rays, fast-fission neutrons, and cyclotron-produced neutrons.
    Balcer-Kubiczek EK; Harrison GH
    Int J Radiat Biol Relat Stud Phys Chem Med; 1983 Oct; 44(4):377-86. PubMed ID: 6605323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of a dose-fractionation effect on neoplastic transformation induced by fission-spectrum neutrons in C3H 10T1/2 cells.
    Saran A; Pazzaglia S; Coppola M; Rebessi S; Di Majo V; Garavini M; Covelli V
    Radiat Res; 1991 Jun; 126(3):343-8. PubMed ID: 2034792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of inverse dose-rate effect on fission neutron induced transformation of C3H/10T1/2 cells.
    Balcer-Kubiczek EK; Harrison GH; Zeman GH; Mattson PJ; Kunska A
    Int J Radiat Biol; 1988 Oct; 54(4):531-6. PubMed ID: 2902151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible error-prone repair of neoplastic transformation induced by fission-spectrum neutrons.
    Hill CK; Han A; Elkind MM
    Br J Cancer Suppl; 1984; 6():97-101. PubMed ID: 6582923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncogenic transformation of C3H 10T1/2 cells by acute and protracted exposures to monoenergetic neutrons.
    Miller RC; Hall EJ
    Radiat Res; 1991 Oct; 128(1 Suppl):S60-4. PubMed ID: 1924750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutron dose-rate experiments at the AFRRI nuclear reactor. Armed Forces Radiobiology Research Institute.
    Balcer-Kubiczek EK; Harrison GH; Hei TK
    Radiat Res; 1991 Oct; 128(1 Suppl):S65-70. PubMed ID: 1924751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoplastic transformation of C3H 10T1/2 cells: a study with fractionated doses of monoenergetic neutrons.
    Saran A; Pazzaglia S; Pariset L; Rebessi S; Broerse JJ; Zoetelief J; Di Majo V; Coppola M; Covelli V
    Radiat Res; 1994 May; 138(2):246-51. PubMed ID: 8183994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of WR-1065 and WR-151326 on survival and neoplastic transformation in C3H/10T1/2 cells exposed to TRIGA or JANUS fission neutrons.
    Balcer-Kubiczek EK; Harrison GH; Hill CK; Blakely WF
    Int J Radiat Biol; 1993 Jan; 63(1):37-46. PubMed ID: 8093466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoplastic transformation is enhanced by multiple low doses of fission-spectrum neutrons.
    Hill CK; Carnes BA; Han A; Elkind MM
    Radiat Res; 1985 Jun; 102(3):404-10. PubMed ID: 4070554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fission-spectrum neutrons at a low dose rate enhance neoplastic transformation in the linear, low dose region (0-10 cGy).
    Hill CK; Han A; Elkind MM
    Int J Radiat Biol Relat Stud Phys Chem Med; 1984 Jul; 46(1):11-5. PubMed ID: 6611317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repair processes and radiation quality in neoplastic transformation of mammalian cells.
    Han A; Hill CK; Elkind MM
    Radiat Res; 1984 Aug; 99(2):249-61. PubMed ID: 6463205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival and oncogenic transformation of C3H/10T1/2 cells after extended X irradiation.
    Balcer-Kubiczek EK; Harrison GH
    Radiat Res; 1985 Nov; 104(2 Pt 1):214-23. PubMed ID: 4080975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of the temporal distribution of dose on oncogenic transformation by neutrons and charged particles of intermediate LET.
    Miller RC; Brenner DJ; Randers-Pehrson G; Marino SA; Hall EJ
    Radiat Res; 1990 Oct; 124(1 Suppl):S62-8. PubMed ID: 2236513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutron-energy-dependent oncogenic transformation of C3H 10T1/2 mouse cells.
    Miller RC; Geard CR; Brenner DJ; Komatsu K; Marino SA; Hall EJ
    Radiat Res; 1989 Jan; 117(1):114-27. PubMed ID: 2913605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of a dose-rate effect in the transformation of C3H 10T1/2 cells by alpha-particles.
    Hieber L; Ponsel G; Roos H; Fenn S; Fromke E; Kellerer AM
    Int J Radiat Biol Relat Stud Phys Chem Med; 1987 Dec; 52(6):859-69. PubMed ID: 3500927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-response relationship of dicentric chromosomes in human lymphocytes obtained for the fission neutron therapy facility MEDAPP at the research reactor FRM II.
    Schmid E; Wagner FM; Romm H; Walsh L; Roos H
    Radiat Environ Biophys; 2009 Feb; 48(1):67-75. PubMed ID: 18979115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transformation of mouse C3H/10T1/2 cells by single and fractionated doses of X-rays and fission-spectrum neutrons.
    Han A; Elkind MM
    Cancer Res; 1979 Jan; 39(1):123-30. PubMed ID: 761182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late mitosis/early G1 phase and mid-G1 phase are not hypersensitive cell cycle phases for neoplastic transformation of HeLa x skin fibroblast human hybrid cells induced by fission-spectrum neutrons.
    Redpath JL; Antoniono RJ; Sun C; Gerstenberg HM; Blakely WF
    Radiat Res; 1995 Jan; 141(1):37-43. PubMed ID: 7527914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.